Publications by authors named "Nicole D Fleming"

Claim this Profile
T
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy.
Roni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin, Bryan M Fellman, Travis T Sims, Nicole D Fleming

Int J Gynecol Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy.
Xiaotian Ma, Yu-Chun Hsu, Amma Asare, Kai Zhang, Deanna Glassman, Nicole D Fleming

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamic immune behavior of primary and metastatic ovarian carcinoma.
Elaine Stur, Fuduan Peng, Pang-Ning Teng, Emine Bayraktar, Min Hu, Nicole D Fleming

NPJ Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.
Jeffrey A How, Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N Westin, Nicole D Fleming

Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study.
Reem Saab, Bryan M Fellman, Alejandra Flores Legarreta, Larissa A Meyer, Nicole D Fleming

Gynecol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative outcomes in gynecologic pelvic exenteration before and after implementation of an enhanced recovery after surgery program.
Sarah P Huepenbecker, Pamela T Soliman, Larissa A Meyer, Maria D Iniesta, Gary B Chisholm, Nicole D Fleming

Gynecol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A colostomy for large bowel obstruction at the end of life: What do patients gain from palliative surgery?
Roni Nitecki Wilke, Maria D Iniesta, Bryan Fellman, Amir A Jazaeri, Larissa A Meyer, Nicole D Fleming

Gynecol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Apixaban for Postoperative Venous Thromboembolism Prophylaxis in Gynecologic Cancer.
Anne Knisely, Nicole D Fleming

Ann Surg Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study.
Patrick Wagner, Edward A Levine, Alex C Kim, Perry Shen, Nicole D Fleming

Ann Surg Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data Acquisition and Intraoperative Tissue Analysis on a Mobile, Battery-Operated, Orbitrap Mass Spectrometer.
Michael F Keating, Charles A Wolfe, Keziah Liebenberg, Ashley Montgomery, Andreia M Porcari, Nicole D Fleming

Anal Chem· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
Emily M Hinchcliff, Anne Knisely, Naomi Adjei, Bryan Fellman, Ying Yuan, Nicole D Fleming

Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center.
Anne Knisely, Maria D Iniesta, Samantha Batman, Larissa A Meyer, Pamela T Soliman, Nicole D Fleming

Gynecol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
Katherine I Foster, Kenna R M Shaw, Jeff Jin, Shannon N Westin, Timothy A Yap, Nicole D Fleming

Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study.
Katherine I Foster, Katelyn F Handley, Deanna Glassman, Travis T Sims, Sanaz Javadi, Nicole D Fleming

Int J Gynecol Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors.
Kaysia Ludford, Won Jin Ho, Jane V Thomas, Kanwal P S Raghav, Mariela Blum Murphy, Nicole D Fleming

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study.
Samantha Batman, Craig A Messick, Andrea Milbourne, Ming Guo, Mark F Munsell, Nicole D Fleming

Cancer Epidemiol Biomarkers Prev· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma.
Emily Hinchcliff, Jennifer Rumpf, Ravin Ratan, Nicole D Fleming, Amir Jazaeri

Gynecol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.
Katelyn F Handley, Travis T Sims, Nicholas W Bateman, Deanna Glassman, Katherine I Foster, Nicole D Fleming

JAMA Netw Open· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.
Sarah P Huepenbecker, Charlotte C Sun, Shuangshuang Fu, Hui Zhao, Kristin Primm, Nicole D Fleming

Int J Gynecol Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes.
Katelyn F Handley, Anil K Sood, Graziela Zibetti Dal Molin, Shannon N Westin, Larissa A Meyer, Nicole D Fleming

Gynecol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer.
Li Zhao, Sara Corvigno, Shaolin Ma, Joseph Celestino, Nicole D Fleming

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.
Christopher J LaFargue, Katelyn F Handley, Nicole D Fleming, Alpa M Nick, Anca Chelariu-Raicu

Gynecol Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer.
Deanna Glassman, Nicholas W Bateman, Sanghoon Lee, Li Zhao, Jun Yao, Nicole D Fleming

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status.
Sara Corvigno, Jared K Burks, Wei Hu, Yanping Zhong, Nicholas B Jennings, Nicole D Fleming

J Cancer Res Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer.
Jeffrey A How, Shrina Patel, Bryan Fellman, Karen H Lu, Patrick Hwu, Nicole D Fleming

Gynecol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis